Prosecution Insights
Last updated: October 02, 2026

Technion Research & Development Foundation Limited

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

38 pending office actions • 33 art units • 38 examiners • 0 of 38 (0%) have an AI response strategy ready • 38 patents granted in the last 365 days

Portfolio Summary

38
Total Pending OAs
23
Non-Final OAs
13
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
1
Due this week
3
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 7 days (1)Due ≤ 30 days (3)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

17
Hard (45%)
16
Medium (42%)
5
Easy (13%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other8 (21%)
§103 only14 (37%)
§112 only4 (11%)
Double-patenting only1 (3%)
Double-patenting + other2 (5%)
Multi-statute (no §101)9 (24%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

25
Life Sciences
66% of docket
2
Information Tech
5% of docket
0
Communications
0% of docket
2
Semiconductors
5% of docket
4
Mechanical / Eng
11% of docket
5
Business / Other
13% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

380 h
Manual time on pending OAs
76 h
Time saved (low, 20%)
133 h
Time saved (mid, 35%)
3.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NGUON, VIRAK 1 83.6% +19.0%
RUBY, TRAVIS C 1 53.9% +27.4%
VELEZ, ROBERTO 1 67.6% +21.4%
VANG, MENG 1 78.2% +26.9%
BERKE-SCHLESSEL, DAVID W 1 66.7% +31.8%
TANINGCO, MARCUS H 1 81.0% +6.6%
WANG, JING 1 100.0% +0.0%
ALLEY, GENEVIEVE S 1 60.3% +48.2%
DARNELL, BAILEIGH K 1 70.2% +26.2%
VIGIL, TORIANA NICHOLE 1 53.1% +24.1%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19248948 SYSTEM AND METHODS FOR FABRICATION OF CURED ARTICLES NGUON, VIRAK —

Hard Cases (17)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17288539 MACHINE LEARNING FOR PROTEIN IDENTIFICATION SABOUR, GHAZAL 30d overdue
17780404 MOLECULAR DATA STORAGE SYSTEMS AND METHODS BAILEY, STEVEN WILLIAM 30d overdue
18269974 CHEMICALLY STABLE ION CONDUCTORS AND USES THEREOF TESKIN, FRED M 20d
17050560 A DEVICE AND METHOD FOR DETERMINING CELL INDENTATION ACTIVITY CHIN, CHRISTOPHER L 23d
18626620 NANO-DELIVERY SYSTEMS COMPRISING MODIFIED LIPIDS AND USE THEREOF ALLEY, GENEVIEVE S 33d
19137274 ENHANCEMENT OF THE THERMOACOUSTIC EFFECT RUBY, TRAVIS C —
18878062 REMOTE EXECUTION VERIFICATION WITH REDUCED RESOURCE REQUIREMENTS VANG, MENG —
18837691 METHODS AND COMPOSITIONS FOR TREATING DIABETES BERKE-SCHLESSEL, DAVID W —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18626620 NANO-DELIVERY SYSTEMS COMPRISING MODIFIED LIPIDS AND USE THEREOF ALLEY, GENEVIEVE S 33d
19248948 SYSTEM AND METHODS FOR FABRICATION OF CURED ARTICLES NGUON, VIRAK —
19137274 ENHANCEMENT OF THE THERMOACOUSTIC EFFECT RUBY, TRAVIS C —
19073091 METHOD AND SYSTEM FOR ANALYZING GAS VELEZ, ROBERTO —
18878062 REMOTE EXECUTION VERIFICATION WITH REDUCED RESOURCE REQUIREMENTS VANG, MENG —
18837691 METHODS AND COMPOSITIONS FOR TREATING DIABETES BERKE-SCHLESSEL, DAVID W —
18421180 ENCAPSULATED QUANTUM CONFINEMENT STRUCTURES AND METHOD OF FABRICATING SAME DARNELL, BAILEIGH K —
18407721 TARGETED MULTIFUNCTIONAL NANOSTRUCTURED LIPID CARRIERS VIGIL, TORIANA NICHOLE —

Top Art Units

Art UnitApps
1742 1
3763 1
2443 1
2884 1
1617 1
1743 1
1612 1
1638 1
1656 1
3694 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19248948 SYSTEM AND METHODS FOR FABRICATION OF CURED ARTICLES NGUON, VIRAK 1742 DP Non-Final OA — Pending Jun 25, 2025
19137274 ENHANCEMENT OF THE THERMOACOUSTIC EFFECT RUBY, TRAVIS C 3763 §102§103 Non-Final OA — Pending Jun 09, 2025
19073091 METHOD AND SYSTEM FOR ANALYZING GAS VELEZ, ROBERTO — §103 Non-Final OA — Pending Mar 07, 2025
18878062 REMOTE EXECUTION VERIFICATION WITH REDUCED RESOURCE REQUIREMENTS VANG, MENG 2443 §101§112 Non-Final OA — Pending Dec 22, 2024
18837691 METHODS AND COMPOSITIONS FOR TREATING DIABETES BERKE-SCHLESSEL, DAVID W — §101§102§103§112 Non-Final OA — Pending Aug 12, 2024
18790246 X-RAY SOURCES TANINGCO, MARCUS H 2884 §102§103 Non-Final OA — Pending Jul 31, 2024
18775072 METHOD AND SYSTEM FOR ATOMIC INTERFEROMETRY WANG, JING — §102§103 Non-Final OA — Pending Jul 17, 2024
18626620 NANO-DELIVERY SYSTEMS COMPRISING MODIFIED LIPIDS AND USE THEREOF ALLEY, GENEVIEVE S 1617 §102§103 Final Rejection 33d Pending Apr 04, 2024
18421180 ENCAPSULATED QUANTUM CONFINEMENT STRUCTURES AND METHOD OF FABRICATING SAME DARNELL, BAILEIGH K 1743 §103 Non-Final OA — Pending Jan 24, 2024
18407721 TARGETED MULTIFUNCTIONAL NANOSTRUCTURED LIPID CARRIERS VIGIL, TORIANA NICHOLE 1612 §103 Final Rejection — Pending Jan 09, 2024
18569642 COMPOSITIONS COMPRISING SPHERICAL PARTICLES AND USES OF SAME VIVLEMORE, TRACY ANN 1638 §103 Non-Final OA — Pending Dec 13, 2023
18522518 PROTEINACEOUS ELECTRODE BINDER WANG, PIN JAN — §102§103 Non-Final OA — Pending Nov 29, 2023
18507493 METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTION LEE, JAE W 1656 §102§103§112DP Non-Final OA — Pending Nov 13, 2023
18557588 ESTIMATING PARAMETERS OF A MODEL THAT IS NON-LINEAR AND IS MORE COMPLEX THAN A LOG-LINEAR MODEL ANDERSON, SCOTT C 3694 §101§103 Final Rejection — Pending Oct 27, 2023
18283091 HYPERGOLIC COMPOSITION FELTON, AILEEN BAKER 1734 §102§103 Non-Final OA — Pending Sep 20, 2023
18273357 RNAI NANOPARTICLES AND METHODS OF USING SAME IN AGRICULTURE HUDSON, AMY ROSE 1636 §102§103§112 Non-Final OA — Pending Jul 20, 2023
18221513 MODIFIED FLUOROQUINOLONES AND USES THEREOF MCDOWELL, BRIAN E 1624 §112 Non-Final OA — Pending Jul 13, 2023
18269974 CHEMICALLY STABLE ION CONDUCTORS AND USES THEREOF TESKIN, FRED M 1762 §102§112 Non-Final OA 20d Pending Jun 28, 2023
18214664 METHODS OF NEURAL INHIBITION FOR TREATING BOWEL DISEASES AND DISORDERS MATTHEWS, CHRISTINE HOPKINS 3791 §101§102§103§112DP Non-Final OA — Pending Jun 27, 2023
18196024 COPLANAR HETEROJUNCTION MONOLITHIC DEVICE AND METHOD OF FABRICATING THE SAME PROSTOR, ANDREW VICTOR 2812 §102§103 Non-Final OA — Pending May 11, 2023
18140177 PREDICTING IMMUNOTHERAPY RESPONSE DUNN, MCKENZIE A 1678 §103 Non-Final OA — Pending Apr 27, 2023
17976084 HARDWARE ARTIFICIAL NEURAL NETWORK (ANN) ANALOG CIRCUIT, AND METHOD OF USING THEREOF BAKER, EZRA JAMES 2126 §103 Final Rejection 9d overdue Pending Oct 28, 2022
17917948 METHOD FOR INDUCING CONDUCTIVITY AT AND NEAR OXIDE INTERFACES MCCLURE, CHRISTINA D 1718 §103 Final Rejection — Pending Oct 10, 2022
17887828 UBIQUITIN LIGASE KPC1 PROMOTES PROCESSING OF P105 NF-KAPPAB1 TO P50, ELICITING STRONG TUMOR SUPPRESSION CANELLA, KAREN A 1643 §112 Non-Final OA 21d Pending Aug 15, 2022
17797763 Method for Production of LixSiyOz Coatings Using a Single Source for Li And Si and Resultant Coated Products TALBOT, BRIAN K 1712 §112 Non-Final OA 66d overdue Pending Aug 05, 2022
17796769 A METHOD FOR ISOLATING A MICROORGANISM GORDON, MELENIE LEE 1651 §103 Final Rejection 6d Pending Aug 01, 2022
17685512 ULTRASOUND MEDIATED POLYMERIZATION FOR CELL DELIVERY, DRUG DELIVERY AND 3D PRINTING SAEED, ALI S 1616 §103 Non-Final OA 11d overdue Pending Mar 03, 2022
17501261 SYSTEM AND METHOD FOR MULTI CHIRAL DETECTION WISE, OLIVIA M. 1685 §103DP Final Rejection — Pending Oct 14, 2021
17602866 FORMULATIONS FOR ENCAPSULATION AND BIOAVAILABILITY IMPROVEMENT OF BIOACTIVE COMPOUNDS BASED ON NATURAL PLANT BASED MATERIALS KETCHAM, KAREN A 1614 §103 Final Rejection 33d Pending Oct 11, 2021
17288539 MACHINE LEARNING FOR PROTEIN IDENTIFICATION SABOUR, GHAZAL 1686 §101§103 Final Rejection 30d overdue Pending Apr 25, 2021
17260428 DETERMINING RESPONDERS TO INFLAMMATION TREATMENT STONEBRAKER, ALYSSA RAE 1642 §101§103§112 Non-Final OA — Pending Jan 14, 2021
17050560 A DEVICE AND METHOD FOR DETERMINING CELL INDENTATION ACTIVITY CHIN, CHRISTOPHER L 1677 §101§102§112 Final Rejection 23d Pending Oct 26, 2020
19104171 INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS LEE, SIN J — §112 Non-Final OA — Pending Feb 14, 2025
17918893 DEVICE AND METHOD FOR GENERATING IMAGE AND DISTANCE INFORMATION RODRIGUEZ, VICENTE M 3642 §103 Non-Final OA 16d overdue Pending Oct 13, 2022
17823933 PROCESS FOR THE MANUFACTURING OF FERMENTED DAIRY PRODUCT SUBSTITUTES DIVIESTI, KARLA ISOBEL 1792 §103 Final Rejection — Pending Aug 31, 2022
18044458 OXYGEN INSENSITIVE AMPEROMETRIC BIOSENSORS SUN, CAITLYN MINGYUN 1795 §103 Non-Final OA — Pending Mar 08, 2023
17780404 MOLECULAR DATA STORAGE SYSTEMS AND METHODS BAILEY, STEVEN WILLIAM 1687 §101§102§103§112 Final Rejection 30d overdue Pending May 26, 2022
17646648 PASTE COMPRISING AMORPHOUS CALCIUM CARBONATE AND DRY 3D MODELS PREPARED THEREFROM LING, DORIS 1764 §103 Final Rejection — Pending Dec 30, 2021

Managing Technion Research & Development Foundation Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month